| HealthPartners | Oncology - fam-trastuzumab deruxtecan-nxki | 2025-04-01 |
| HealthPartners | Oncology - inotuzumab ozogamicin (Besponsa™) – | 2025-04-01 |
| HealthPartners | Oncology - luspatercept-aamt (Reblozyl®) | 2025-04-01 |
| HealthPartners | Oncology - luspatercept-aamt (Reblozyl®) – Minnesota | 2025-04-01 |
| HealthPartners | Oncology - polatuzumab vedotin-piiq (Polivy™) – | 2025-04-01 |
| HealthPartners | Oncology - tagraxofusp-erzs (Elzonris™) | 2025-04-01 |
| HealthPartners | Oncology - tagraxofusp-erzs (Elzonris™) – Minnesota | 2025-04-01 |
| HealthPartners | Oncology - talimogene laherparepvec (Imlygic®) – | 2025-04-01 |
| HealthPartners | Oncology - trabectedin (Yondelis®) – Minnesota | 2025-04-01 |
| HealthPartners | Oncology** - immune globulin therapy | 2025-04-01 |